Inhibition of TNF-a mediated cytotoxicity in L-929 mouse fibrosarcoma cells in the presence of the metabolic inhibitor actinomycin D: ED50 = typically 1-3µg/mL in the presence of 0.25ng/mL recombinant human TNF-a.
Purity
>95% (by SDS-PAGE).
Product Form
Lyophilized
Concentration
Reconstitution dependent.
Formulation
Lyophilized from Phosphate Buffered Saline, pH 7.4 (0.22µm filter sterilized).
Endotoxin Level
<0.1 EU/µg of the protein by LAL method.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C up to 1 year from the date of receipt. Reconstituted: Aliquot and store at -20°C for 3 months or 2-8°C for up to 1 week. Avoid freeze/thaw cycles.
Synonyms
CD120b, p75, p80 TNF-alpha receptor, TNF-R2, TNF-RII, TNFBR, TNFR-II, TNFR2, Tumor necrosis factor receptor 2, Tumor necrosis factor receptor superfamily member 1B, Tumor necrosis factor receptor type II
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Recombinant Human TNFRSF1B Protein (C-terminal His Tag) (A331350)
TNF-a mediated cytotoxicityin L-929 mouse fibrosarcoma cells in the presence of the metabolic inhibitor actinomycin D inhibited by Recombinant Human TNFRSF1B Protein (C-terminal His Tag) (A331350): ED50 = typically 1-3µg/mL in the presence of 0.25 ng/mL Recombinant human TNF-a.
Publishing research using Recombinant Human TNFRSF1B Protein (C-terminal His Tag) (A331350)? Please let us know so that we can list the citation on this page.
Alternative products to Recombinant Human TNFRSF1B Protein (C-terminal His Tag) (A331350)